# VanEck Biotech ETF (BBH)

> Source: Nexqual · https://nexqual.com/BBH · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, VanEck Biotech ETF (BBH), nexqual.com/BBH" · informational, not investment advice.

**Price:** USD 246.57 (-0.38% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 247.51 · day 246.05–247.69 · 52w 176.3–251.45 · market cap null · NGM

## Key facts
- Total return with dividends: 1Y +39.6% vs S&P 500 +13.4%; 5Y +26.6% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +39.6% | +26.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +39.8% | +4.8% |
| Volatility (annualized) | 22.3% | 21.6% |
| Max drawdown | -10.6% (Jan 2026→May 2026) | -31.3% (Oct 2021→Jun 2022) |

## Peers
PPH (VanEck Pharmaceutical ETF) USD 114.93 -1.80% · HHH (Howard Hughes Holdings Inc.) USD 70.19 +1.01% · RTH (VanEck Retail ETF) USD 267.89 -1.72% · FBT (First Trust Amex Biotech Index ) USD 269.25 -1.26% · PBE (Invesco Biotechnology & Genome ) USD 98.72 -0.67%

## More
Full page: https://nexqual.com/BBH · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 27 | 26.9% | ±6.0% |
| 2026-12-18 | 55 | 25.3% | ±7.9% |
| 2027-03-19 | 146 | 25.0% | ±12.7% |
| 2027-06-17 | 236 | 24.8% | ±16.0% |